Monitoring cardiovascular rehabilitation outcomes in Switzerland
Official title: Swiss Secondary Prevention and Rehabilitation Registry: SwissPR
Run by University Hospital, Basel, Switzerland · NCT05500859 · Data updated 2026-11-12
This study looks at how a 12-week heart rehabilitation program in Switzerland affects patients' heart health and helps identify those at higher risk for heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 4000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | December 20, 2019 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | July 22, 2025 |
| Trial ID | NCT05500859 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals of all age groups who are participating in an ambulatory cardiac rehabilitation program and can provide informed consent.
✕Probably not a fit
Patients who are unable to follow an ambulatory cardiac rehabilitation program for more than three weeks or who cannot provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The SwissPR study is a longitudinal observational cohort study that aims to monitor patient characteristics and benchmark quality measures for individuals participating in a 12-week ambulatory cardiac rehabilitation program at the University Hospital Basel. It includes both retrospective and prospective data collection to assess the impact of the rehabilitation program on cardiovascular health outcomes. The study seeks to identify patients at higher cardiovascular risk and understand the factors influencing secondary prevention behaviors. By creating a comprehensive registry, the study addresses the lack of data on the Swiss population's experiences during and after cardiac rehabilitation.
Why it matters
Potential benefit: If successful, this study could improve the quality of cardiac rehabilitation programs and enhance patient outcomes for those with cardiovascular diseases.
How similar studies have gone: Other studies have shown success in monitoring rehabilitation outcomes, but this specific registry approach is novel for the Swiss population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participation in an ambulatory CR program (all age groups) * Written informed consent Exclusion Criteria: * Inability to follow an ambulatory CR program more than 3 weeks * Not willing to give informed consent * Inability to understand the informed consent due to language comprehension * Lack of discernment
Where it's running
-
University Hospital Basel, Division of Outpatient Cardiology
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Otmar Pfister, Prof. Dr. med. — Outpatient Cardiology, University Hospital Basel
- Study coordinator: Otmar Pfister, Prof. Dr. med.
- Email: otmar.pfister@usb.ch
- Phone: +41 61 328 7482
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Colchicine to see if it reduces coronary artery inflammation in people with HIV
This study tests whether low-dose colchicine can lower inflammation in the coronary arteries of people with HIV who are at high heart-disease risk, compared with a placebo.
-
Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation
This trial tests the Laplace TTVR System to see if it safely and effectively treats adults with severe tricuspid regurgitation.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.